Detalles de la búsqueda
1.
Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting ß2-agonist, in patients with asthma: results of a parallel-group study and a crossover study.
Respir Res
; 16: 97, 2015 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26283085
2.
Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma.
J Allergy Clin Immunol
; 124(6): 1217-21, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20004781
3.
Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2-4 COPD: results from two replicate 48-week studies.
Int J Chron Obstruct Pulmon Dis
; 9: 697-714, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25045258
Resultados
1 -
3
de 3
1
Próxima >
>>